- July 11, 2016Kyorin Pharmaceutical and Kaken Pharmaceutical signed a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadine"
- June 1, 2016Release of Eklira 400μg Genuair 60 inhalations, a treatment for COPD
- May 25, 2016MSD's investigational antiallergic agent desloratadine to be exclusively marketed by Kyorin
- March 30, 2016Kyorin and Kissei signed an Agreement for Co-Development and Co-Marketing of KRP-114V
- February 23, 2016Announcement Regarding Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」
- February 3, 2016Termination of License Concerning COPD Therapeutic Drug KRP-AB1102F
- December 11, 2015Release of KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhinitis
- December 11, 2015NHI Drug Price Listing of PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease